ProCE Banner Activity

Venetoclax + Decitabine or Azacitidine in Elderly Treatment-Naive Patients With AML

Slideset Download
Conference Coverage
Combining venetoclax with azacitidine or decitabine as initial therapy was tolerable and active in elderly patients with AML.

Released: December 10, 2015

Expiration: December 08, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen